Prognostic value of DLGAP5 in colorectal cancer.
Adult
Aged
Aged, 80 and over
Cell Line, Tumor
Cell Movement
Cell Proliferation
Chromosomal Instability
Colorectal Neoplasms
/ metabolism
Female
Humans
Intestines
/ pathology
Lymph Nodes
/ pathology
Male
Middle Aged
Neoplasm Invasiveness
Neoplasm Proteins
/ metabolism
Neoplasm Recurrence, Local
/ pathology
Prognosis
Stem Cells
/ metabolism
Survival Analysis
Colorectal cancer
DLG7
DLGAP5
Metastasis
Survival
Journal
International journal of colorectal disease
ISSN: 1432-1262
Titre abrégé: Int J Colorectal Dis
Pays: Germany
ID NLM: 8607899
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
accepted:
19
06
2019
pubmed:
10
7
2019
medline:
14
1
2020
entrez:
10
7
2019
Statut:
ppublish
Résumé
DLG7 (disc large homolog 7) is a microtubule-associated protein encoded by DLGAP5 (DLG associated protein 5) gene and has an important role during spindle assembly. Spindle assembly deregulation is a well-known cause of genomic instability. The aim of this study was to investigate the influence of DLGAP5 expression on survival and to evaluate its potential use as a biomarker in colorectal cancer (CRC). DLGAP5 expression was measured in the primary tumor and corresponding normal mucosa samples from 109 patients with CRC and correlated to clinical and pathological data. The results were validated in a second, publically available patient cohort. Molecular effects of DLG7/DLGAP5 in CRC were analyzed via functional assays in knockdown cell lines. DLGAP5 downregulation led to a significant reduction of the invasion and migration potential in CRC. In addition, DLGAP5 expression correlates with nodal status and advanced UICC stage (III-IV).Subgroup analyses revealed a correlation between DLGAP5 overexpression and poor survival in patients with non-metastatic disease (M0). Furthermore, overexpression of DLGAP5 is associated with worse overall survival in distinct molecular CRC subtypes. The results of this study suggest the importance of DLGAP5 in defining a more aggressive CRC phenotype. DLG7/DLGAP5 represents a potential biomarker for CRC in molecular subgroups of CRC.
Identifiants
pubmed: 31286215
doi: 10.1007/s00384-019-03339-6
pii: 10.1007/s00384-019-03339-6
doi:
Substances chimiques
DLGAP5 protein, human
0
Neoplasm Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1455-1465Subventions
Organisme : DFG
ID : WE 3548/4-1/2
Références
Cancer Cell. 2005 Jul;8(1):7-12
pubmed: 16023594
Biochem Pharmacol. 2012 Mar 15;83(6):758-68
pubmed: 22230478
PLoS One. 2013 Dec 09;8(12):e82833
pubmed: 24349376
Anticancer Res. 2003 May-Jun;23(3B):2729-33
pubmed: 12894566
Gastrointest Cancer Res. 2010 Nov;(Suppl 1):S16-23
pubmed: 21472043
Cell Stem Cell. 2011 May 6;8(5):511-24
pubmed: 21419747
Mol Cell Biol. 2005 Jul;25(14):5789-800
pubmed: 15987997
Clin Cancer Res. 2014 Apr 15;20(8):2159-68
pubmed: 24486594
Stem Cells. 2007 Jun;25(6):1498-506
pubmed: 17322106
Oncotarget. 2016 Dec 20;7(51):84258-84270
pubmed: 27713177
Cancer Cell. 2005 Jul;8(1):75-87
pubmed: 16023600
Breast Cancer Res Treat. 2012 Apr;132(3):1025-34
pubmed: 21773767
Genes Chromosomes Cancer. 2012 Jun;51(6):545-56
pubmed: 22337647
Nat Rev Cancer. 2005 Jan;5(1):42-50
pubmed: 15630414
PLoS One. 2011;6(10):e26323
pubmed: 22022601
Sci Rep. 2018 May 14;8(1):7522
pubmed: 29760449
Curr Opin Genet Dev. 2001 Feb;11(1):83-90
pubmed: 11163156
Oncotarget. 2016 Aug 2;7(31):49322-49333
pubmed: 27384994
Eur J Endocrinol. 2012 Jan;166(1):61-7
pubmed: 22048964
Curr Biol. 2006 Apr 18;16(8):731-42
pubmed: 16631580
J Biol Chem. 2004 Jul 30;279(31):32592-602
pubmed: 15145941
J Pathol. 2013 Sep;231(1):63-76
pubmed: 23836465
Clin Cancer Res. 2009 Dec 15;15(24):7642-7651
pubmed: 19996206
BMC Cancer. 2010 Dec 23;10:691
pubmed: 21176237
Cell. 2001 Jan 12;104(1):83-93
pubmed: 11163242
Nat Genet. 2006 Sep;38(9):1043-8
pubmed: 16921376
Nature. 2012 Jul 18;487(7407):330-7
pubmed: 22810696
J Clin Oncol. 2014 Jan 1;32(1):57-9
pubmed: 24043748
J Cell Biol. 2006 Jun 19;173(6):879-91
pubmed: 16769820
Mol Biol Cell. 2008 May;19(5):2083-91
pubmed: 18321990
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
J Neuropathol Exp Neurol. 2011 Jan;70(1):1-12
pubmed: 21157382
Breast Cancer Res Treat. 2013 Jul;140(2):219-32
pubmed: 23836010
Oncogene. 2003 Jan 16;22(2):298-307
pubmed: 12527899
Genomics. 2001 Sep;77(1-2):5-7
pubmed: 11543626
Curr Biol. 2011 Sep 27;21(18):1584-91
pubmed: 21924616
J Clin Oncol. 2009 Mar 1;27(7):1108-15
pubmed: 19139432